Abbvie Inc

ABBV-AT:Vienna Stock Exchange
*Data is delayed | EUR
Last | 3:09 PM CET
88.33quote price arrow down-1.85 (-2.05%)
Volume
780
52 week range
0.00 - 89.94

...

Loading . . .

KEY STATS

  • Open89.62
  • Day High89.94
  • Day Low88.10
  • Prev Close90.18
  • 52 Week High89.94
  • 52 Week High Date01/27/21
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap195,700.56M
  • Shares Out1,765.29M
  • 10 Day Average Volume-
  • Dividend4.46
  • Dividend Yield5.05%
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)3.90
  • P/E (TTM)22.65
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Abbvie Inc News

There is no recent news for this security.

Latest ABBV-AT News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's...
Richard Gonzalez
Chairman
Carlos Alban
Vice Chairman - Management
Laura Schumacher
Vice Chairman - Management
Michael Severino M.D.
President
Robert Michael
Chief Financial Officer
Henry Gosebruch
Executive Vice President
Address
1 N Waukegan Rd
North Chicago, IL
60064-1802
United States